✦ LIBER ✦

S92 Impact of radiation therapy plus hormonal therapy in patients affected by high risk prostate cancer

✍ Scribed by G.C. Mattiucci; G. Mantini; G. De Dilectis; V. Frascino; L. Tagliaferri; N. Dinapoli; S. Luzi; D. Smaniotto; S. Fersino; E. Mazzeo; E. Ciurlia; N. Cellini

Book ID: 119620533
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 59 KB
Volume: 8
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(09)74973-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of high-risk prostate cancer:

Management of high-risk prostate cancer: Radiation therapy and hormonal therapy

✍ Nomiya, Takuma; Tsuji, Hiroshi; Toyama, Shingo; Maruyama, Katsuya; Nemoto, Kenji 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 351 KB

Primary Radiation Therapy Is Equivalent

Primary Radiation Therapy Is Equivalent to Robotic Prostatectomy Plus Adjuvant Radiation Therapy in Patients With High-Risk Prostate Cancer

✍ Arora, S.; Singh, P.; Christos, P.; Wernicke, A.; Nori, D.; Chao, K.; Parashar, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 63 KB

S206 Radiation therapy for high risk sub

S206 Radiation therapy for high risk subgroup of prostate cancer patients

✍ Synesiou, M.; Anagnostou, T.; Simopoulou, F.; Stokidis, S.; Katrafilova, M.; Arv 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Impact of neoadjuvant hormonal therapy o

Impact of neoadjuvant hormonal therapy on dose-volume histograms in patients with localized prostate cancer under radical radiation therapy

✍ Pilar M. Samper; Concepción López Carrizosa; Ana Pérez Casas; Carmen Vallejo; M; 📂 Article 📅 2006 🏛 Springer Milan 🌐 Spanish ⚖ 707 KB

7030 POSTER Outcomes of Intensity-Modula

7030 POSTER Outcomes of Intensity-Modulated Radiation Therapy Combined With Neoadjuvant Hormonal Therapy for High-risk Prostate Cancer

✍ Mizowaki, T.; Norihisa, Y.; Ogura, M.; Kamba, T.; Inoue, T.; Shimizu, Y.; Kamoto 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Initial decline in hemoglobin during neo

Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer

✍ Anthony V. D'Amico; Tara Saegaert; Ming-Hui Chen; Andrew A. Renshaw; Daniel Geor 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract ## BACKGROUND Declines in serum hemoglobin (Hgb) levels occur from the use of androgen suppression therapy (AST) in the treatment of prostate cancer patients. We studied whether time to prostate specific antigen (PSA) failure following external beam radiation therapy (RT) and AST could